Prospect Capital Corporation vs Revvity Inc — how do they compare? Prospect Capital Corporation trades at $2.15 (market cap $1.08B), while Revvity Inc trades at $110.67 (market cap $12.33B). The key difference: Revvity Inc is far larger — about 11.4× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (23.26%). Which is the better fit depends on your goals.
| PSEC | RVTY | |
|---|---|---|
Market Cap | $1.08B | $12.33B |
Sector | Financials | Technology |
52-Week High | $3.47 | $117.75 |
52-Week Low | $2.15 | $82.26 |
Dividend Yield | 23.26% | 0.25% |
Enterprise Value | — | $14.82B |
Trailing returns across standard periods
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →